Vital Annex: International Journal of Novel Research in Advanced Sciences (ijnras)



Yüklə 431,8 Kb.
Pdf görüntüsü
səhifə4/6
tarix08.04.2023
ölçüsü431,8 Kb.
#95083
1   2   3   4   5   6
396-401 Reasons for the Development of Morphostructural Changes in Kidney Cells in Patients with Rheumatoid Arthritis

List of used literature: 
1. Axmatovna M. S. et al. Peculiarities of the morphophenotype and characteristics of the physical 
performance of young football players and their relationship with the gaming amplitude 
//Academicia: an international multidisciplinary research journal. – 2021. – Т. 11. – №. 2. – С. 
1381-1388. 
2. Crowson CS, Matteson EL, Myasoedova E, et al. The lifetime risk of adult-onset rheumatoid 
arthritis and other inflammatory autoimmune rheumatic dis-eases // Arthritis Rheum. 2011 
Mar;63(3):633-9.doi:10.1002/art.30155
3. England BRM, Mikuls TR. Epidemiology of, risk factors for, and possible causes of rheumatoid 
ar-thritis.2020. 
4. Fernández-Nebro A, Tomero E, Ortiz-Santamaría V, et al. Treatment of rheumatic inflamma-
tory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha 
antagonists // Am J Med. 2005;118(5):52-556.doi:10.1016/j.am-jmed.2005.01.028
5. Gois M, Carvalho F, Sousa H, et al. Renal involvement in rheumatoid arthritis: analysis of 53 
renal biopsies. Port J Nephrol Hypert. 2017;31(1):25-30. 
6. Galarraga B, Khan F, Kumar P, et al. C-reactive protein: the underlying cause of icrovascular 
dysfunction in rheumatoid arthritis. Rheumatology (Oxford). 2008;47(12):1780-4. doi: 
0.1093/rheumatology/ken386 
7. Gottenberg JE, Merle-Vincent F, Bentaberry F, et al. Anti-tumor necrosis factor alpha therapy 
in fif-teen patients with AA amyloidosis secondary to inflam-matory arthritides: a followup 


Vital Annex: International Journal of Novel Research in Advanced Sciences 
(IJNRAS) 
Volume: 01 Issue: 05 | 2022 ISSN: 2751-756X  
http://innosci.org 
 
399 | Page 
report 
of 
tolerability 
and 
efficacy 
// 
Arthritis 
Rheum. 
2003;48(7):2019-2024. 
doi:10.1002/art.11163
8. Hickson LJ, Crowson CS, Gabriel SE, et al. Development of reduced kidney function in 
rheumatoid arthritis. Am J Kidney Dis. 2014;63:206-13. doi: 0.1053/j.ajkd.2013.08.010
9. Helin HJ, Korpela MM, Mustonen JT, Pasternack AI. Renal biopsy findings and 
clinicopathologic correlations in rheumatoid arthritis. Arth Rheum. 1995;38(2):242-7. doi: 
10.1002/art.1780380213 
10. Helin H.J., Korpela M.M., Mustonen J.T., Pasternack A.I. Renal biopsy findings and 
clinicopathologic correlations in rheumatoid arthritis // Arthritis Rheum. 1995. V. 38 (2). P. 
242—247.
11. Hickson LJ, Crowson CS, Gabriel SE. Development of Reduced Kidney Function in 
Rheumatoid Arthritis. Am J Kidney Dis 2014;63(2): 206-213
12. Ifuku M., Miyake K., Watanebe M. et al. Various roles of Th cytokine mRNA expression in 
different formsof glomerulonephritis. Amer. J. Nephrol. 2013; 38 (2):115–123. DOI: 
10.1159/000353102. 
13. Imig J.D., Ryan M.J. Immune and inflammatory role in renal disease. Compr. Physiol. 2013; 3 
(2): 957–976.DOI: 10.1002/cphy.c120028
14. Ingrasciotta Y., Sultana J., Giorgianni F. et al. Association of Individual Non-Steroidal Anti- 
Inflammatory Drugs and Chronic Kidney Disease: A Population-Based Case Control Study // 
PLoS One. – 2015; 10 (4): e0122899. DOI: 10.1371/journal.pone.0122899. 
15. Jesky M, Lambert A, Burden A. The impact of chronic kidney disease and cardiovascular 
comorbidity on mortality in a multiethnic population: a retrospective cohort study. BMJ Open 
2013;3(12). doi 10.1136/bmjopen-2013-003458
16. Joss N., McLaughlin K., Simpson K., Boulton-Jones J. M.// Q. J. Med.— 2000.— Vol. 93.— P. 
535—542. 
17. Kapoor T, Bathon J. Renal manifestations of rheumatoid arthritis//Rheumatic Disease Clin-
ics.2018;44:4:571-584.doi:10.1016/j.rdc.2018.06.008
18. Kim HW, Lee CK, Cha HS, et al. Effect of anti-tumor necrosis factor alpha treatment of 
rheumatoid arthritis and chronic kidney disease. Rheumatol Int. 2015;35(4):727-34. doi: 
10.1007/s00296-014-3146-4
19. Khamroyeva Y.S. Early Diagnosis of Systemic Scleroderma // Procedia of Engineering and 
Medical Sciences-2022. №01.P.31-38. 
20. Kochi M, Kohagura K, Shiohira Y, et al. In-flammation as a Risk of Developing Chronic 
Kidney Disease in Rheumatoid Arthritis // PLOS ONE. 2016. doi:10.1371/journal.pone.016022
21. Koseki Y., Terai C., Moriguchi M. et al. A prospective study of renal disease in patients with 
early rheumatoid arthritis // Ann. Rheum. Dis. 2001. V. 60 (4). P. 327—331
22. Kurts Ch., Panzer U., Anders H.-J., Rees A.J. The immune system and kidney disease: basic 
concepts and clinical implications. Nature Rev. Immunol. 2013; 13: 738–753. DOI: 
0.1038/nri3523
23. LV. Revmatoidnyj artrit kak osnovnaya prichina razvitiya AAamiloidoza.Klinicheskaya 
gerontologiya. 2009;15(2):14-20 (In Russ.) 



Yüklə 431,8 Kb.

Dostları ilə paylaş:
1   2   3   4   5   6




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©azkurs.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin